newsfilter
← Latest News
PR Newswire·

Acasti Pharma Announces 1-for-6 Reverse Stock Split

LAVAL, QB, July 7, 2023 /PRNewswire/ -- Acasti Pharma Inc. ("Acasti" or the "Company") (NASDAQ:ACST), a late-stage, biopharma company advancing GTX-104, its novel formulation of nimodipine that addresses